col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


7 Ergebisse       Seite 1

 [1] 
Oxford University Press: Immunotherapy Advances
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Nov―06 Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022 Megan V C Barnes, Anika Mandla, Emma Smith, Maija Maskuniitty, Peter J M Openshaw, Yara-Natalie Abo, et al. (+34)
2 [GO] 2023―Mrz―15 A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses Paul R Buckley, Chloe H Lee, Agne Antanaviciute, Alison Simmons, Hashem Koohy
3 [GO] 2021―Dez―30 Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy Dongyan Zhou, Runhong Zhou, Zhiwei Chen
4 [GO] 2021―Aug―17 The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunization with adenovirus vector-based SARS-CoV-2 vaccines Eleanor R Gaunt, Neil A Mabbott
5 [GO] 2021―Jul―02 Peripheral T cell lymphopenia in COVID-19: Potential mechanisms and impact Sifan Zhang, Becca Asquith, Richard Szydlo, John S Tregoning, Katrina Pollock
6 [GO] 2021―Jun―02 Targeting immunometabolism to treat COVID-19 Shane Myles O’Carroll, Luke A J O’Neill
7 [GO] 2021―Feb―17 CSF1R defines the Mononuclear Phagocyte System lineage in human blood in health and COVID-19 Theo W Combes, Federica Orsenigo, Alexander Stewart, A S Jeewaka R Mendis, Deborah Dunn-Walters, Siamon Gordon, Fernando O Martinez
 [1] 

7 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec